Empyrean Capital Partners’s Global Business Travel Group, Inc. Warrants, each exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share GBTG.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-1,165,660
Closed -$1.83M 134
2022
Q3
$1.83M Hold
1,165,660
0.06% 105
2022
Q2
$1.22M Buy
+1,165,660
New +$1.35M 0.04% 123

Empyrean Capital Partners's GBTG.WS Position: Q4 2022 in Review

Empyrean Capital Partners sold out of Global Business Travel Group, Inc. Warrants, each exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share (GBTG.WS) in Q4 2022, closing a stake of 1,165,660 shares — an estimated $1.83M sold.

Empyrean Capital Partners first reported a position in GBTG.WS in Q2 2022 and held it in 2 quarters. The position peaked at $1.83M in Q3 2022. 0 funds tracked by Wall St. Rank hold GBTG.WS as of Q4 2022.

  • Empyrean Capital Partners reported no remaining Global Business Travel Group, Inc. Warrants, each exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share position as of Q4 2022 after selling out during the quarter.
  • Empyrean Capital Partners sold 1,165,660 Global Business Travel Group, Inc. Warrants, each exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share shares in Q4 2022, an estimated $1.83M.
  • Empyrean Capital Partners first reported a position in Global Business Travel Group, Inc. Warrants, each exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share in Q2 2022 and held it in 2 quarters.
  • Empyrean Capital Partners's Global Business Travel Group, Inc. Warrants, each exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share position peaked at $1.83M in Q3 2022.
  • 0 funds tracked by Wall St. Rank held Global Business Travel Group, Inc. Warrants, each exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share as of Q4 2022.

Based on Empyrean Capital Partners's 13F filing for Q4 2022, filed 14 Feb 2023.